US health costs to surge 6.7% in 2026, hitting 15-year high
Health benefit costs per employee in the U.S. are expected to rise 6.7% year-over-year in 2026 to at least $18,500, the largest increase in 15 years. Employers are planning to raise deductibles and premiums, while prescription drug costs are projected to climb 9%. Policy efforts are underway to address drug pricing, but high costs and coverage gaps persist.

*this image is generated using AI for illustrative purposes only.
Health benefit costs per employee in the U.S. are expected to rise 6.7% year-over-year in 2026 to at least $18,500, marking the biggest annual increase in 15 years. The surge signals growing financial pressure on both employers and workers, with health insurers projected to raise the cost of employer group plans by more than 6% for the fourth consecutive year.
The findings come from a report by Mercer released on June 11, which was highlighted by market commentator The Kobeissi Letter. The report indicates that nearly half of large U.S. employers are expected to raise deductibles, copays, or other out-of-pocket costs for workers in 2027. Additionally, around 66% of large U.S. firms may increase monthly employee premium contributions next year.
Workers who frequently visit doctors and fill prescriptions could see healthcare costs rise by as much as 8% year-over-year. "U.S. healthcare costs have never been higher," The Kobeissi Letter wrote.
Rising Prescription Drug Costs
The increasing cost burden is being driven partly by expensive prescription drugs, including specialty medications, gene therapies, and GLP-1 treatments such as Ozempic and Wegovy. Prescription drug benefit costs alone are expected to rise around 9% in 2026.
In response to these rising expenses, Mercer found that 6% of large employers dropped weight-loss GLP-1 coverage in 2026, while 27% tightened utilization controls.
Employer Strategies and Policy Responses
Employers are increasingly redesigning health plans to control spending. About 31% of large employers already offer or plan to offer non-traditional plans in 2027, such as high-performance networks or variable copay models that reduce costs when workers use approved providers.
Simon Camaj, Mercer's U.S. Health Leader, stated that employers are using a mix of traditional cost-sharing tactics and alternative care strategies to manage another year of elevated health benefit cost growth while attempting to minimize the impact on employees.
Policymakers are also targeting prescription drug inflation. The Trump administration said its drug-pricing agreements with major pharmaceutical companies could save the U.S. economy $529 billion over the next decade, according to White House estimates.
| Metric | Projected Change/Value |
|---|---|
| Health benefit cost increase (2026) | 6.7% year-over-year |
| Cost per employee (2026) | At least $18,500 |
| Prescription drug cost increase (2026) | Around 9% |
| Employers raising deductibles/copays (2027) | Nearly 50% |
| Employers raising monthly premiums (2027) | Around 66% |
The affordability crisis extends beyond insured workers. Recent CDC data showed the U.S. uninsured rate remained at 8.3% in 2025, leaving roughly 28 million Americans without health coverage, while millions more remain underinsured. Sen. Bernie Sanders (I-Vt.) argued that despite the U.S. spending more than $15,000 per person on healthcare, tens of millions remain uninsured or underinsured.
Will the removal of GLP-1 coverage by 6% of large employers accelerate in 2027 as weight-loss drug demand continues to surge?
How effective will non-traditional plans like high-performance networks be in curbing costs without significantly reducing employee access to care?
Could the projected 6.7% cost increase force small and medium-sized businesses to drop health coverage entirely, further raising the uninsured rate?

































